Middle meningeal artery embolization for resistant chronic migraine
Part of Brain & nervous system, Pain clinical trials.
This study tests a procedure called 'middle meningeal artery embolization' using a special glue-like material (SQUID) to treat chronic migraine that hasn't responded to other treatments. The goal is to see if blocking blood flow to the membrane around the brain can reduce migraine attacks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 35 and 59 years old.
- You have had chronic migraine (headaches on 15+ days per month for at least 3 months) for more than a year.
- Your migraine has not improved with several treatments, including Botox injections.
- In the past month, you had at least 14 headache days, 8 of which were migraine days, with pain level 5 or more out of 10.
- You do not have other headache types, serious heart or blood vessel disease, blood clotting problems, or other major medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure called bilateral middle meningeal artery embolization to see if it reduces chronic migraine symptoms in people who haven't found relief from other treatments. It's for those with frequent, disabling migraines that affect both sides of the head.
This study follows adults who undergo a procedure called middle meningeal artery embolization—a minimally invasive treatment that blocks blood flow to a specific artery thought to trigger migraines. The trial simply tracks your symptoms and quality of life before and after the procedure to understand how well it works.
This study tests a procedure called MMA embolization (blocking a small artery in the head) to see if it can reduce migraine attacks in people with chronic, hard-to-treat migraines.
This trial tests a minimally invasive procedure that blocks a blood vessel in the brain to reduce migraine attacks. It may help people who have frequent migraines and haven't found relief with standard migraine medications.
This trial tests a procedure called middle meningeal artery embolization, which aims to stop the bleeding and reduce the fluid buildup from a chronic subdural hematoma. It may be an option for patients who have a hematoma at least 10mm thick and one or more risk factors such as older age, blood thinners, diabetes, or certain scan features.
This trial looks at how well a procedure called middle meningeal artery embolization works for people with chronic subdural hematoma (a collection of old blood on the brain's surface). It uses specific materials to block the blood supply to the hematoma, which may help the body reabsorb it without surgery.
Hear when a new Chronic Migraine Headache trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.